secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kiromic Biopharma, Inc. (—)
CIK:        0001792581
Form:       8-K
Filed at:   2023-06-12T23:59:59+00:00
Accession:  0001104659-23-070367
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Kiromic BioPharma appoints Brian Hungerford as interim CFO
----------------------------------------------------------

- Appointed Brian Hungerford as interim Chief Financial Officer effective June 12, 2023.
- Mr. Hungerford was retained through an agreement with Element 78 Partners, LLC.
- No departure of prior CFO or other officers was disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1792581/000110465923070367/0001104659-23-070367-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1792581/000110465923070367/tm2318467d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-070367

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer